It now includes oral GLP-1 drugs, amylin combinations, dual agonists, triple agonists, long-acting platforms, and differentiated assets designed for durability, tolerability, access, or broader metabolic indications
Frontiers in Oncology , 12, 858462
The relative lack of side effects is particularly important for those with recurring or chronic pain, as it lowers the risks associated with multiple injections
A GLP-1 pill offers a chance to push that progress even further if we can figure out how to expand access and how to better support patients so they can lose weight in a healthy way
This applies even more to populations at higher-relative risk such as the elderly, those with pre-existing PDR or prolonged DM, individuals on multiple medications for their diabetes, and those who experience rapid reductions in either body weight or blood glucose
Researchers are responsible for ensuring compliance with all applicable regulations, institutional policies, and laboratory protocols